Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.

Yonglin PuJames X ZhangHaiyan LiuDaniel AppelbaumJianfeng MengBill C Penney

Published in: European journal of nuclear medicine and molecular imaging (2018)

This study developed and validated a novel MTVwb risk stratification system, which has prognostic value independent of the TNM stage and other clinical prognostic factors in NSCLC, suggesting that it could be used for further NSCLC pretreatment assessment and for refining treatment decisions in individual patients.

Keyphrases

prognostic factors
small cell lung cancer
end stage renal disease
ejection fraction
newly diagnosed
advanced non small cell lung cancer
chronic kidney disease
smoking cessation
tyrosine kinase